Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Shrivastava S, Mahantshetty U, Engineer R, Tongaonkar H, Kulkarni J, Dinshaw K. Treatment and outcome in cancer cervix patients treated between 1979 and 1994: A single institutional experience. J Cancer Res Ther. 2013;9(4):672–9.
Manders DB, et al. Locally advanced cervical cancer: outcomes with variable adherence to treatment. Am J Clin Oncol. 2018;41(5):447–51.
Lee JW, Seol KH. Pretreatment neutrophil-to-lymphocyte ratio combined with platelet-to-lymphocyte ratio as a predictor of survival outcomes after definitive concurrent chemoradiotherapy for cervical cancer. J Clin Med. 2021;10(10):2199.
Article PubMed PubMed Central Google Scholar
Cho O, Chun M. Management for locally advanced cervical cancer: new trends and controversial issues. Radiat Oncol J. 2018;36(4):254.
Article PubMed PubMed Central Google Scholar
Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44.
Article PubMed CAS Google Scholar
Lee Y-Y, et al. Pretreatment neutrophil: lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res. 2012;32(4):1555–61.
Carvalho HA, Villar RC. Radiotherapy and immune response: the systemic effects of a local treatment. Clinics. 2018;73:e557s.
Gangopadhyay A. Prognostic nutritional index and clinical response in locally advanced cervical cancer. Nutr Cancer. 2020;72(8):1438–42.
Article PubMed CAS Google Scholar
Gao Z, Zhao M, Yang X, Fu J. Assessment of peripheral platelet to lymphocyte ratio and prognostic nutritional index in the efficacy and prognosis of radiotherapy for cervical cancer. Curr Oncol. 2023;30(3):2834–44.
Article PubMed PubMed Central Google Scholar
Ménétrier-Caux C, Ray-Coquard I, Blay J-Y, Caux C. Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines? J Immunother cancer. 2019;7:1–15.
Alečković M, McAllister SS, Polyak K. Metastasis as a systemic disease: molecular insights and clinical implications. Biochim Biophys Acta BBA Reviews Cancer. 2019;1872:89–102.
Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol. 2004;4(8):641–8.
Article PubMed CAS Google Scholar
Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021;14:1–17.
Onal C, Guler OC, Yildirim BA. Prognostic use of pretreatment hematologic parameters in patients receiving definitive chemoradiotherapy for cervical cancer. Int J Gynecol Cancer. 2016;26:6.
Jankova L, Dent OF, Chan C, Chapuis P, Clarke SJ. Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer. BMC Cancer. 2013;13:1–13.
Templeton AJ, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):124.
Wang H-B, et al. Prognostic values of the prognostic nutritional index, geriatric nutritional risk index, and systemic inflammatory indexes in patients with stage IIB–III cervical cancer receiving radiotherapy. Front Nutr. 2023;10:1000326.
Article PubMed PubMed Central Google Scholar
Mizunuma M, Yokoyama Y, Futagami M, Aoki M, Takai Y, Mizunuma H. The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer. Int J Clin Oncol. 2015;20:989–96.
Article PubMed CAS Google Scholar
Huang H, et al. Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer. Sci Rep. 2019;9(1):3284.
Article PubMed PubMed Central Google Scholar
Chao B, Ju X, Zhang L, Xu X, Zhao Y. A novel prognostic marker systemic inflammation response index (SIRI) for operable cervical cancer patients. Front Oncol. 2020;10:766.
Article PubMed PubMed Central Google Scholar
Haraga J, et al. Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy. Mol Clin Oncol. 2016;5(5):567–74.
Article PubMed PubMed Central CAS Google Scholar
Bossi P, Delrio P, Mascheroni A, Zanetti M. The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients. 2021;13(6):1980.
Article PubMed PubMed Central Google Scholar
Tian M, Fu H, Du J. Application value of NRS2002 and PG-SGA in nutritional assessment for patients with cervical cancer surgery. Am J Transl Res. 2021;13(6):7186.
PubMed PubMed Central Google Scholar
Graziano V, et al. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients. The Breast. 2019;44:33–8.
Ida N, Nakamura K, Saijo M, Kusumoto T, Masuyama H. Prognostic nutritional index as a predictor of survival in patients with recurrent cervical cancer. Mol Clin Oncol. 2018;8(2):257–63.
Xiao L, et al. Clinical application value of the Prognostic Nutritional Index for predicting survival in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy or radiotherapy. Nutr Cancer. 2021;73(10):1933–40.
Comments (0)